The Discounted Cash Flow (DCF) valuation of Cue Biopharma Inc (CUE) is (7,786.96) USD. With the latest stock price at 37.05 USD, the upside of Cue Biopharma Inc based on DCF is -21117.4%.
Based on the latest price of 37.05 USD and our DCF valuation, Cue Biopharma Inc (CUE) is a sell. selling CUE stocks now will result in a potential gain of 21117.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.5% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (38,430.75) - (4,348.60) | (7,786.96) |
| Upside | -103826.7% - -11837.1% | -21117.4% |